.

Name : Mr. SATYAM GUPTA

Lab No. : 176772327 Age : 28 Years
Ref By : DR MUKUND KHETAN Gender : Male
Collected : 10/2/2024 12:24:00PM Reported : 10/2/2024 5:14:34PM
A/c Status : P Report Status : Final
Collected at : LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at : LPL-NATIONAL REFERENCE LAB
National Reference laboratory, Block E, National Reference laboratory, Block E,
Sector 18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085

Test Report

Test Name Results Units Bio. Ref. Interval

PROTHROMBIN TIME STUDIES

(Photo - Optical clot detection)
Mean Normal Prothrombin Time (PT) 11.00 sec

Patient value 10.40 sec 9.70 - 12.40

Prothrombin Ratio (PR) 0.95

International Normalized Ratio (INR) 0.95 0.90 - 1.10

Note
1. INR is the parameter of choice in monitoring adequacy of oral anticoagulant therapy. Appropriate
therapeutic range varies with the disease and treatment intensity
2. Prolonged INR suggests potential bleeding disorder / bleeding complications
3. Results should be clinically correlated
4. Test conducted on Citrated plasma

Recommended Therapeutic range for Oral Anticoagulant therapy

INR 2.0-3.0 :
· Treatment of Venous thrombosis & Pulmonary embolism
· Prophylaxis of Venous thrombosis (High risk surgery)
· Prevention of systemic embolism in tissue heart valves, AMI, Valvular heart disease &
Atrial fibrillation
· Bileaflet mechanical valve in aortic position
INR 2.5-3.5:
§ Mechanical prosthetic valves
§ Systemic recurrent emboli

Comments
Prothrombin time measures the extrinsic coagulation pathway which consists of activated Factor VII (VIIa),
Tissue factor and Proteins of the common pathway (Factors X, V, II & Fibrinogen). This assay is used to
control long term oral anticoagulant therapy, evaluation of liver function & to evaluate coagulation disorders
specially factors involved in the extrinsic pathway like Factors V, VII, X, Prothrombin & Fibrinogen.

*176772327*
Page 1 of 5
.

Name : Mr. SATYAM GUPTA

Lab No. : 176772327 Age : 28 Years
Ref By : DR MUKUND KHETAN Gender : Male
Collected : 10/2/2024 12:24:00PM Reported : 10/2/2024 5:14:34PM
A/c Status : P Report Status : Final
Collected at : LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at : LPL-NATIONAL REFERENCE LAB
National Reference laboratory, Block E, Sector National Reference laboratory, Block E,
18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085

Test Report
Test Name Results Units Bio. Ref. Interval

HIV 1 & 2 ANTIBODIES SCREENING TEST, SERUM

--------------------------------------------------------------------------
| Final Result :Negative Negative |
--------------------------------------------------------------------------

HIV 1 / 2 & P 24 COMBO TEST

(CMIA)
Index Value 0.06 Index <1.00

Result Non Reactive

-----------------------------------------------------------------------------------
|Result (Index) | REMARKS | INTERPRETATION |
|---------------|--------------|----------------------------------------------------|
| >=1 | Reactive | Indicates Presence of antibodies to HIV Virus |
|---------------|--------------|----------------------------------------------------|
| <1 | Non-Reactive | Indicates absence of antibodies to HIV Virus |
-----------------------------------------------------------------------------------

*It is advised to verify all positive results by conducting the supplemental HIV 1 and HIV2 antibody
confirmation and differentiation, LIA (S315).
Note
1. Positive test result indicates antibody detected against HIV-1/2 in all the three tests done by
different methodology.
2. Negative test result indicates antibody is not detected against HIV- 1/2.
3. Indeterminate test result indicates antibody to HIV-1/2 have been detected in the sample by two of
three methods.
4. Results are reported as per the Strategy 3 of National guidelines of HIV testing by NACO, July 2017.
5. False positive results may be observed in Autoimmune diseases, Alcoholic hepatitis, Primary
biliary cirrhosis, Leprosy, Multiple pregnancies, Rheumatoid factor, and due to presence of
heterophile antibodies.
6. False negative results may occur during the window period and during the end stage of the
disease.
Recommendations
1. Post-test counseling available between 9 am to 5 pm at LPL laboratories.

*176772327*
Page 2 of 5
.

Name : Mr. SATYAM GUPTA

Lab No. : 176772327 Age : 28 Years
Ref By : DR MUKUND KHETAN Gender : Male
Collected : 10/2/2024 12:24:00PM Reported : 10/2/2024 5:14:34PM
A/c Status : P Report Status : Final
Collected at : LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at : LPL-NATIONAL REFERENCE LAB
National Reference laboratory, Block E, Sector National Reference laboratory, Block E,
18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085

Test Report

Test Name Results Units Bio. Ref. Interval

HEPATITIS B SURFACE ANTIGEN;HBsAg, SERUM Non Reactive Non Reactive

(CMIA)
*Specific Antibody Neutralization Assay is performed on all Reactive results.
Interpretation
-------------------------------------------------------------------
| RESULT | REMARKS |
|--------------|----------------------------------------------------|
| Reactive | Indicates presence of Hepatitis B Surface Antigen. |
|--------------|----------------------------------------------------|
| Non-Reactive | Indicates absence of Hepatitis B Surface Antigen. |
-------------------------------------------------------------------

Note
1. Reactive test result indicates presence of Hepatitis B Surface Antigen. It cannot differentiate between
the stages of Hepatitis B viral infection.
2. Non-Reactive test result indicates absence of Hepatitis B Surface Antigen.
3. False positive results may be observed in patients receiving mouse monoclonal antibodies, on
heparin therapy, on biotin supplements for diagnosis or therapy, in pregnancy, presence of
heterophilic antibodies in serum or after HBV vaccination for transient period of time.
4. False negative reaction may be due to processing of sample collected early in the course of disease
or presence of mutant forms of HBsAg .
5. For monitoring HBsAg levels, Quantitative HBsAg assay is recommended.

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*176772327*
Page 3 of 5
.

Name : Mr. SATYAM GUPTA

Lab No. : 176772327 Age : 28 Years
Ref By : DR MUKUND KHETAN Gender : Male
Collected : 10/2/2024 12:24:00PM Reported : 10/2/2024 5:14:34PM
A/c Status : P Report Status : Final
Collected at : LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at : LPL-NATIONAL REFERENCE LAB
National Reference laboratory, Block E, Sector National Reference laboratory, Block E,
18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085

Test Report

Test Name Results Units Bio. Ref. Interval

HEPATITIS C ANTIBODY (Anti-HCV), SERUM 0.06 Index <1.00

(CMIA)
Interpretation
---------------------------------------------------------------------------------------------
| RESULT (INDEX) | REMARKS | INTERPRETATION |
|------------------|-----------------|--------------------------------------------------------|
| <1.00 | Non-Reactive | Indicates absence of antibodies to Hepatitis C virus |
|------------------|-----------------|--------------------------------------------------------|
| >=1.00 | Reactive | Indicates presence of antibodies to Hepatitis C virus. |
---------------------------------------------------------------------------------------------

* It is recommended to confirm all reactive results with the HCV antibody confirmatory test (S314).*

Note
1. Reactive test result indicates presence of Hepatitis C virus infection. It cannot differentiate between
the stages of Hepatitis C viral infection nor used to monitor the efficacy of treatment.
2. Non-Reactive test result indicates Hepatitis C virus infection is unlikely.
3. False positive results may be observed in patients receiving mouse monoclonal antibodies, on
heparin therapy, on biotin supplements for diagnosis or therapy or presence of heterophilic antibodies
in serum.
4. False negative reaction may be due to processing of sample collected early in the course of disease,
Prozone phenomenon, Immunosuppression & Immuno-incompetence.
5. Test conducted on serum.
Uses
1. To diagnose suspected HCV infection in risk group.
2. Prenatal Screening of pregnant women and pre surgical/interventional procedures work up.

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*176772327*
Page 4 of 5
.

Name : Mr. SATYAM GUPTA

Lab No. : 176772327 Age : 28 Years
Ref By : DR MUKUND KHETAN Gender : Male
Collected : 10/2/2024 12:24:00PM Reported : 10/2/2024 5:14:34PM
A/c Status : P Report Status : Final
Collected at : LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at : LPL-NATIONAL REFERENCE LAB
National Reference laboratory, Block E, Sector National Reference laboratory, Block E,
18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085

Test Report

Test Name Results Units Bio. Ref. Interval

Dr Ajay Gupta Dr Gurleen Oberoi Dr Jatin Munjal Dr Sarita Kumari Lal

MD, Pathology DM(Hematopathology), MD,Pathology MD, Pathology
Technical Director - Hematology & MD,DNB,MNAMS Consultant Pathologist Consultant Pathologist
Immunology Senior Consultant and Lead- Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd
NRL - Dr Lal PathLabs Ltd Hematopathology
NRL - Dr Lal PathLabs Ltd

Dr Shalabh Malik Dr Sunanda

MD, Microbiology
Technical Director - Microbiology,
Infectious Disease Molecular &
Serology, Clinical Pathology
NRL - Dr Lal PathLabs Ltd
MD, Pathology
Sr. Consultant Pathologist -
Hematology & Immunology
NRL - Dr Lal PathLabs Ltd

-------------------------------End of report --------------------------------

AHEEEHAPMKHIBICNLKACCJLCBILLJCECCIKCIKPJNKEDFFFAPPAHEEEHA
BNFFFNBPAPBKJGAGFGEHAGIPAOAHFHAKAGJOBCJCBLEKMOJHNPBNFFFNB
CIEGEEFJLPMCNFJOPFIAAJHFJAFEHEDDNKPHENFLMLKIOEFLBLGDEHANP
DJPFIAFNBHDIEDIBGLNELFMFANHLALAFJIFEOAPAKCLJPDNLILFBKEMEK
LDDNLHFJONNFDIAPIBFCKPJBBENBOLKHKKMFECOIPLKGKPNGKFFFOOKND
MGCBBEFMNICGDJEKILAKDIPBADHFOFAINDFCBKDLBLIKONNALNEIPGEKD
LDIMIJFJELOPDEDIEKMMEFGHIHAFJBAKOPGPBLMOOJCHKJFHIJNJIDILD
NJJJAMFNAKPMIMDJGANHDMHILKBMFMBFOFCCAMNNIIKNOPNKBNFMBHILL
NKIMCDFDCIDGFAAEJOOIHIEKHOEFEKFBJFFLBKPFOOBIOCNKDJPHNEKLJ
MNAEGBFCEHJJJDCCBJNFGPNFKDFKPNJHKEPHEPNLNKCKIGEOCEKKHOGJL
KCIKOLFLGKCBMMAMPJBNPJEEINMPGJABJMFEBFOEONDMKPFKEPCIGKIEG
IGICGJFCPLDGDBLMHHGGJNDEIEOPPFOFBGHPBLNOOLJBIKNINKONHDICL
MNNNNNEHCFDAOKKJOCFLHJJHJBAHFHADPKPFCMNLMKJCLFNMAHFHAHIKL
APBBBPAPBAEAEJBLFOCKCNCFAHECHHCAONFEPKPGOLMHNLNNEDFFCBKHH
HHHHHHHPHPHPHPPPHHHPPPHHPPPPPPPPPPPPHHPPPHHHPHPHHHHPPHPHP

IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost for
derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe Courts/Forum
at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid for medico legal
purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical Practitioner /Doctor.ŸThe report does
not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: lalpathlabs@lalpathlabs.com
National Reference lab, Delhi, a CAP (7171001) Accredited, ISO 9001:2015 (FS60411) & ISO 27001:2013 (616691) Certified laboratory.

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*176772327*
Page 5 of 5